# FDA Inspection 1030020 - GlaxoSmithKline Vaccines S.r.l. - May 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/a22d58f4-696a-4e53-88fb-f0c6c3c6ed78
Source feed: FDA_Inspections

> FDA Inspection 1030020 for GlaxoSmithKline Vaccines S.r.l. on May 29, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030020
- Company Name: GlaxoSmithKline Vaccines S.r.l.
- Inspection Date: 2017-05-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 683109 - 2010-06-18](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/15846114-2c1f-4413-9b81-69d6daf5d89f)

Company: https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/cddb07b7-c8a6-4dbd-a92c-c6ebeeb7e009

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d